Trial · NCT02553993
Comparing the Cognitive Effects of Two Exergame Training and Traditional Training in Patients With Chronic Stroke
NCT02553993, Not applicable, Completed, Chang Gung Memorial Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Comparing the Cognitive Effects of Two Exergame Training and Traditional Training in Patients With Chronic Stroke. Trials, record NCT02553993. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02553993
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparing the Cognitive Effects of Two Exergame Training and Traditional Training in Patients With Chronic Stroke
- NCT number
- NCT02553993
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 43 participants, actual
- Lead sponsor
- Chang Gung Memorial Hospital
- Conditions
- Stroke
- Interventions
- Wii Fit(30 Mins), Tetrax biofeedback(30 Mins), Conventional weight-shifting(30 Mins)
- First posted
- 2015-09-18
- Last updated
- 2016-01-08
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in Cognitive Abilities Screening Instrument Scale Chinese version (CASI C-2.0) | Subjects will be assesed at 12 weeks and 24 weeks | The CASI C-2.0 consists of 20 item sets, which can be divided into 9 domains, including long-term memory, short-term memory, attention, concentration or mental manipulation, orientation, abstraction/judgment, language, visual construction, and category fluency. The CASI scores range from 0 to 100, with higher scores indicating better cognitive performance. |
| Secondary | Change from Baseline in The Stroop test | Subjects will be assesed at 12 weeks and 24 weeks | The Stroop test requires selective attention, response inhibition, and working memory. The Stroop score ranges from 0 to 63, with higher scores indicating better performance. |
| Secondary | Change from Baseline in The modified Trail Making Test(TMT) | Subjects will be assesed at 12 weeks and 24 weeks | The modified Trail Making Test (TMT) requires visual scanning, visuo-motor tracking, divided attention, and cognitive flexibility. The shorter time to complete the test means better performance. |
| Secondary | Change from Baseline in The digit backward performance | Subjects will be assesed at 12 weeks and 24 weeks | The digit backward performance requires attention and working memory. The scores range from 2 to 7 higher scores indicating better performance. |
| Secondary | Change from Baseline in Physiological profile assessment(PPA) | Subjects will be assesed at 12 weeks and 24 weeks | The PPA is a validated battery of sensorimotor measurements used to identify those subjects at risk of falling. |
| Secondary | Change from Baseline in The 10m walking test | Subjects will be assesed at 12 weeks and 24 weeks | The 10m WT is a reliable, valid, and responsive measure for sub-acute stroke. Walking speed will be assessed by self-selected gait speed over 10 m. The shorter time it takes is indicating better performance. |
| Secondary | Change from Baseline in Tetrax balance system | Subjects will be assesed at 12 weeks and 24 weeks | Tetrax balance system will be used to assess static standing balance. The lower risk scores is indicating better performance. |
| Secondary | Change from Baseline in Timed Up and Go (TUG) test | Subjects will be assesed at 12 weeks and 24 weeks | Timed Up and Go (TUG) test will be used to assessed Dynamic balance function. The shorter time it take means better performance. |
| Secondary | Change from Baseline in The Frenchay Activities Index (FAI) | Subjects will be assesed at 12 weeks and 24 weeks | The Frenchay Activities Index (FAI) was used as a measure of subjects' participation level. The 15-item index records the frequency of performing social activities as well as more complex activities of daily living (eg, domestic chores, outdoor mobility, leisure, gainful work). The FAI item score is based on the frequency with which an activity was performed, and ranges from 0 (low frequency) to 3 (high frequency). Ten items concern the past 3 months and 5 items concern the past 6 months. The FAI total score is the sum of item scores, and ranges from 0 (inactive) to 45 (highly active). |
| Secondary | Change from Baseline in Stroke Impact Scale | Subjects will be assesed at 12 weeks and 24 weeks | The Stroke Impact Scale (SIS) is a 59-item self-reported scale with good reliability, validity, and sensitivity to change. The SIS consists of 8 functional domains: strength, memory, emotion, communication, ADL/ instrumental ADL (IADL), mobility, hand function, and participation. The overall SIS score represents the average score of the 8 domains. Each item score ranges from 1 to 5. Each domain score has a range of 0 to 100 and is computed by using the following equation: Score =\[(Mean - 1)/(5 - 1)\] × 100. In this equation, the score is that of a particular domain, and the mean is the average of the item scores within that domain. A higher score on an item denotes better performance. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers36
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02553993
GET https://conductscience.org/api/trials/v1/NCT02553993/papers?page=2